Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer

This publication has 14 references indexed in Scilit:

• Natural History of Progression After PSA Elevation Following Radical Prostatectomy
  JAMA, 1999
• Pretreatment Nomogram for Prostate-Specific Antigen Recurrence After Radical Prostatectomy or External-Beam Radiation Therapy for Clinically Localized Prostate Cancer
  Journal of Clinical Oncology, 1999
• Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
  JAMA, 1998
• A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer
  JNCI Journal of the National Cancer Institute, 1998
• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
  Published by American Medical Association (AMA) ,1997
• Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml
  International Journal of Radiation Oncology*Biology*Physics, 1997
• State T1–2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Analysis of Risk Factors for Progression in Patients with Pathologically Confined Prostate Cancers After Radical Retropubic Prostatectomy
  Journal of Urology, 1996
• Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and Ratios
  Journal of Urology, 1995
• Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques.
  Radiology, 1994